IP Library Granted Patent US 10,640,763
Granted Patent B2
US 10,640,763 · App. 15/596,364 · Granted May 5, 2020

Molecular indexing of internal sequences

Inventors: Glenn Fu (Menlo Park, CA); Eleen Shum (Menlo Park, CA)
Assignee: Cellular Research, Inc.
C12N15/1065C12Q1/6806C12Q1/6844C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,640,763
App. No.
15/596,364
Granted
May 5, 2020
Kind
B2
Abstract

The present disclosure relates to compositions, methods and kits for labeling an internal sequence of a target nucleic acid molecule with molecular barcodes. In some embodiments, the methods comprise intramolecular circulation of a labeled target nucleic acid molecule. Further provided methods for generating sequencing libraries comprising overlapping fragments covering the full length of a target nucleic acid molecule, sequencing the libraries using the methods disclosed herein, and methods of analyzing sequencing results therefrom.

Claims (25)

1. A method of labeling a target nucleic acid sequence in a sample with a molecular barcode, comprising:

hybridizing an oligonucleotide comprising a molecular barcode with a first nucleic acid molecule comprising the target nucleic acid sequence;

extending the oligonucleotide to generate a second nucleic acid molecule comprising the molecular barcode and the target nucleic acid sequence;

circularizing the second nucleic acid molecule or complement thereof to generate a circularized nucleic acid molecule comprising the molecular barcode in close proximity to the target nucleic acid sequence; and

amplifying the circularized nucleic acid molecule to generate a plurality of amplicons comprising the molecular barcode in close proximity to the target nucleic acid sequence, wherein one or more amplification reactions use at least one primer comprising a binding site for a sequencing primer, wherein the sequencing primer does not comprise a sequence homologous to the sequence of the first nucleic acid molecule.

2. The method of claim 1 , further comprising synthesizing a complementary strand of the second nucleic acid molecule to generate a double-stranded nucleic acid molecule.

3. The method of claim 2 , wherein the circularizing comprises circularizing the double-stranded nucleic acid molecule.

4. The method of claim 1 , further comprising amplifying the second nucleic acid molecule or complement thereof to generate a copy of the second nucleic acid molecule or complement thereof.

5. The method of claim 4 , wherein the circularizing comprises circularizing a copy of the second nucleic acid molecule or complement thereof.

6. The method of claim 1 , further comprising sequencing the plurality of amplicons.

7. The method of claim 1 , wherein the first nucleic acid is an mRNA.

8. The method of claim 1 , wherein the oligonucleotide specifically binds to a binding site on the first nucleic acid molecule.

9. The method of claim 8 , wherein the binding site is a gene-specific sequence.

10. The method of claim 8 , wherein the binding site is a poly-A sequence.

11. The method of claim 1 , wherein the target nucleic acid sequence comprises 20 nt to 30 nt.

12. The method of claim 1 , wherein the target nucleic acid sequence comprises 30 nt to 40 nt.

13. The method of claim 1 , wherein the target nucleic acid sequence comprises 40 nt to 50 nt.

14. The method of claim 8 , wherein the binding site is at least 200 nt away from the target nucleic acid sequence on the first nucleic acid molecule.

15. The method of claim 8 , wherein the binding site is at least 500 nt away from the target nucleic acid sequence on the first nucleic acid molecule.

16. The method of claim 8 , wherein the binding site is at least 1,000 nt away from the target nucleic acid sequence on the first nucleic acid molecule.

17. The method of claim 8 , wherein the binding site is at least 2,000 nt away from the target nucleic acid sequence on the first nucleic acid molecule.

18. The method of claim 1 , wherein the molecular barcode comprises a sample label, a cellular label, a molecular label, or a combination thereof.

19. The method of claim 1 , wherein the molecular barcode comprises a binding site for a primer.

20. The method of claim 19 , wherein the primer is a universal primer.

21. The method of claim 1 , wherein the sequencing primer is a sequence associated with a high-throughput sequencing platform.

Assignments (3)
MERGER Recorded Oct 9, 2020
From: TUCSON ACQUISITION CORP.
To: CELLULAR RESEARCH, INC.
Reel/Frame 054037/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2020
From: CELLULAR RESEARCH, INC.
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 054111/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2017
From: FU, GLENN; SHUM, ELEEN
To: CELLULAR RESEARCH, INC.
Reel/Frame 042761/0265 →
Continuity (2)
Provisional Application 62343574 · May 31, 2016
Related Publication 20170342405A1 · Nov 30, 2017